HepaRegenix

Tubingen, Germany · Founded 2015 · Privately Held (backing)

Developer of novel therapies designed to treat acute and chronic liver diseases. HepaRegenix is based in Tubingen, Germany and was founded in 2015. Its last reported valuation was $43.2 million in Jan 2020. It has raised $45.3 million.

Last reported valuation

$43.2M

Oct 2026

Priced at

—

Total raised

$45.3M

Last round

—

How much has HepaRegenix raised?

$45.3Macross 0 recorded rounds

Free account

More of HepaRegenix with a free account

·Watch HepaRegenix: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

HepaRegenix investors

7 investors are on record for HepaRegenix, including High-Tech Gründerfonds, Novo Holdings, Boehringer Ingelheim Venture Fund and Wellington Partners.

For fundraisers

Raising for a company like HepaRegenix?

7 investors have backed HepaRegenix.

See all 7 investors →

Frequently asked about HepaRegenix

How much has HepaRegenix raised?: HepaRegenix has raised $45.3M in total across 0 recorded funding rounds.